Global Placental Stem Cells Pscs Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 240.00 Million |
 Market Size (Forecast Year) |
USD 382.52 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球胎盘干细胞 (PSCS) 市场，按服务类型（样品保存和储存、样品分析、样品处理、样品收集和运输）、应用（个性化银行应用、研究应用、临床应用）划分 - 行业趋势和预测到 2030 年。
胎盘干细胞 (PSCS) 市场分析及规模
多能干细胞 (PSC) 为治疗药物和再生细胞疗法的发现和测试开辟了新的机会，有助于我们了解发育生物学。尽管 PSC 研究在过去 30 年中迅速发展，越来越接近治疗用途，但这些细胞仍未完全被了解。多能干细胞 (PSC) 的生成、特性和培养的基本思想得到了广泛认可。尽管研究已经基本消除了与 PSC 的起源和培养相关的危害和问题，但伦理问题仍然存在，而诱导多能干细胞 (iPSC) 的发展有助于解决这些问题。未来的多能干细胞研究和再生疗法无疑将受到 iPSC 和 PSC 是否实际上相同的问题的影响。
Data Bridge Market Research 分析，胎盘干细胞 (PSCS) 市场在 2022 年为 10 亿美元，预计到 2030 年将达到 49.1 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 22%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
胎盘干细胞 (PSCS) 市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
服务类型（样本保存与存储、样本分析、样本处理、样本采集与运输）、应用（个性化银行应用、研究应用、临床应用） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
CBR Systems, Inc (U.S.), Cordlife India (India), Cryo-Cell International, Inc. (U.S.), ESPERITE N.V. (Netherlands), LifeCell International Pvt. Ltd. (India), StemCyte India Therapeutics Pvt. Ltd (India), PerkinElmer Inc (U.S.), Global Cord Blood Corporation (Hong Kong), Smart Cells International Limited (U.K.), Vita 34 (Germany) |
|
Market Opportunities |
|
Market Definition
The term "pluripotent stem cells" (PSCs) refers to a class of cells that have the ability to differentiate into the majority. PSCs are useful tools for studying the biology of cells at the molecular level as well as for simulating diseases and the development of new drugs. Differentiated PSCs can be used to evaluate cardiac and hepatic toxicity, two key contributors to the morbidity and mortality linked to pharmaceutical use that generate attrition in the pipeline for developing new drugs.
Placental Stem Cells (PSCS) Market Dynamics
Drivers
- Recent advancements
As stated previously, improvements in approaches for directed differentiation, cell tracking, gene function analysis, and gene correction have been made possible by recent rapid developments in the genetic engineering of hPSCs. The nuclease-based technologies, such as ZFNs, TALENs, and CRISPR/Cas9, promise to simplify and improve genetic modifications in hPSCs and their offspring through their high success rates and ease of design.
• Increasing funding for stem cell research projects
The demand for better and more advanced treatments for auto-immune, neurological and coronary heart disease has increased cell-based research funding and cumulative research efforts. For instance, in June 2021, $6.3 million was granted to the University of Sydney for three initiatives that address adult vision loss, cardiovascular events and expanding access to stem cell interventions. The California Institute for Regenerative Medicine granted Stanford physician-researchers approximately $31 million in the same year to start first-in-human trials of stem treatments for treating stroke, heart failure, and a particular form of brain and spinal cord malignancy. These are some of the elements driving the market's expansion.
Opportunities
- Rising number of product launches
The market is anticipated to be driven by an increase in product releases by major industry participants during the forecast period. For instance, in August 2017, the healthcare services company LifeCell unveiled an enhanced umbilical cord-stem cell collection kit that safeguards neonatal stem cells from environmental deterioration and temperature changes.
Restraints/Challenges
- Rising operating expenses
The growth of the placental stem cells (PSCS) market during the above-mentioned forecast period is projected to be hampered by rising operating expenses and a strict regulatory environment. The largest barrier to market expansion will be social and ethical considerations.
本胎盘干细胞 (PSCS) 报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关胎盘干细胞 (PSCS) 市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球胎盘干细胞 (PSCS) 市场范围
胎盘干细胞 (PSCS) 市场根据服务类型和应用进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
服务类型
- 样品保存与储存
- 样本分析
- 样品处理
- 样品采集和运输
应用
- 个性化银行应用程序
- 研究应用
- 疾病治疗研究
- 生命科学研究
- 药物研发
- 临床应用
- 造血系统疾病
- 自身免疫性疾病
- 其他疾病
胎盘干细胞 (PSCS) 市场区域分析/见解
对胎盘干细胞 (PSCS) 市场进行分析，并按上述国家、服务类型和应用提供市场规模洞察和趋势。
胎盘干细胞（PSCS）报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美在胎盘干细胞 (PSCS) 市场占据主导地位，因为该地区拥有完善的医疗保健基础设施和优惠的报销政策。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
胎盘干细胞 (PSCS) 还为您提供每个国家/地区资本设备医疗保健支出增长、胎盘干细胞 (PSCS) 市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对胎盘干细胞 (PSCS) 市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和胎盘干细胞 (PSCS) 市场份额分析
胎盘干细胞 (PSCS) 竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对胎盘干细胞 (PSCS) 市场的关注有关。
胎盘干细胞（PSCS）领域的一些主要参与者包括：
- CBR Systems, Inc（美国）
- Cordlife India（印度）
- Cryo-Cell International, Inc.（美国）
- ESPERITE NV（荷兰）
- LifeCell International Pvt. Ltd.（印度）
- StemCyte India Therapeutics Pvt. Ltd（印度）
- PerkinElmer Inc（美国）
- 全球脐带血公司（香港）
- Smart Cells International Limited（英国）
- Vita 34（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
